Clinical trial

Acute Application Of Intrawound Antibiotic Powder In Open Extremity Fracture Wounds

Name
20-2957
Description
The purpose of this study is to help determine the best treatment for severe injures like open fracture wounds. Some broken bone injuries can be more likely to get an infection. It is mostly due to the way they were injured. Surgical site infection in the orthopedic surgery population is a big public health issue. Wound infections result in both longer length of hospital stay and total cost of care. This study will be using an antibiotic called Vancomycin or Tobramycin in a powder form.
Trial arms
Trial start
2021-06-14
Estimated PCD
2023-09-30
Trial end
2023-09-30
Status
Completed
Phase
Early phase I
Treatment
Vancomycin
1 vial of Vancomycin 1g powder applied topically to the open fracture wound injury.
Arms:
Vancomycin
Tobramycin
1 vial of Tobramycin 1.2g powder applied topically to the open fracture wound injury.
Arms:
Tobramycin
Size
20
Primary endpoint
Incidence of surgical site infection during the post-operative follow-up period
Within 6 months of injury date
Eligibility criteria
Inclusion Criteria: * Subject or proxy willing and able to provide written informed consent. * Age between 18 years and 80 years (inclusive), with an upper or lower extremity Gustilo Type II, IIIA, or IIIB open fractures requiring debridement and internal fixation. * Open extremity fractures * Time from injury to study intervention 24 hours or less Exclusion Criteria: * Individuals under the age of 18 years or over 80 years * Type I or IIIC open fractures * Over 24 hours from time of injury * Subjects who have received acute operative care of the open fracture at an outside facility prior to presenting at the Emergency Department. * Open fractures distal to the wrist and midfoot * History of chronic infection in the extremity involved. * Subjects who are currently pregnant * Subjects who are Prisoners * Subjects with a known allergy to vancomycin or tobramycin * Subjects with a condition or social circumstances that would reduce adherence and follow-up. * Subjects Participating in other clinical research involving investigational antimicrobial products within 30 days of randomization.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'The management of open fractures involves an expedited administration of systemic antibiotics and while effective in reducing the rate of infection, complications from infections are still common following open fractures. This trial aims to evaluate the incidence of surgical site infections using topical vancomycin antibiotic powder or topical tobramycin antibiotic powder in combination with standard of care treatment and to evaluate the effectiveness of both topical antibiotic powders in reducing surgical site infection.', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'SINGLE', 'maskingDescription': 'This will be a single-blind study as only the participants will be blinded to the treatment.', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 20, 'type': 'ACTUAL'}}
Updated at
2024-02-05

1 organization

2 products

7 indications

Product
Vancomycin
Indication
Fracture
Indication
Open
Indication
Bone
Product
Tobramycin